Literature DB >> 10891597

Angiotensin AT(2) receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells.

U Stroth1, A Blume, K Mielke, T Unger.   

Abstract

To investigate the influence of AT(2) receptor stimulation on the ERK pathway and elucidate potential mechanisms of angiotensin II (ANG II)-mediated neuronal differentiation, we analysed tyrosine phosphorylation and activity of ERK after ANG II treatment of both quiescent and NGF-treated PC12W cells. Tyrosine phosphorylation of ERK1 and ERK2 corresponded with the activity of ERK. While ANG II induced an initial activation of ERK in quiescent cells, the NGF-mediated plateau of ERK-stimulation was lowered by costimulation with ANG II. All effects of ANG II were sensitive to AT(2) - but not AT(1) receptor blockade. Ang II-mediated neurite outgrowth in PC12W cells was inhibited by co-treatment with the MEK inhibitor PD 098059. These findings demonstrate that the AT(2) receptor modulates ERK activity depending on the overall cellular input. The distinct regulation of ERK by ANG II and NGF further indicates basic differences in AT(2) receptor- and NGF-induced neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891597     DOI: 10.1016/s0169-328x(00)00093-0

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  14 in total

Review 1.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

4.  Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.

Authors:  Gali Umschweif; Sigal Liraz-Zaltsman; Dalia Shabashov; Alexander Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

5.  Cross-talk between angiotensin II and glucagon receptor signaling mediates phosphorylation of mitogen-activated protein kinases ERK 1/2 in rat glomerular mesangial cells.

Authors:  Xiao C Li; Oscar A Carretero; Jia L Zhuo
Journal:  Biochem Pharmacol       Date:  2006-03-28       Impact factor: 5.858

Review 6.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

7.  Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production.

Authors:  Isha Dhande; Wanshu Ma; Tahir Hussain
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

8.  Angiotensin II increased neuronal stem cell proliferation: role of AT2R.

Authors:  Jie Chao; Lu Yang; Shilpa Buch; Lie Gao
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

9.  How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-19       Impact factor: 5.555

10.  The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Int J Hypertens       Date:  2012-12-25       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.